Weight loss set to be pharmas gain - Globes
| EPIT Stock | 947.50 10.50 1.10% |
About 61% of Epitomee Medical's investor base is looking to short. The analysis of current outlook of investing in Epitomee Medical suggests that many traders are alarmed regarding Epitomee Medical's prospects. The current market sentiment, together with Epitomee Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Epitomee Medical stock news signals to limit their universe of possible portfolio assets.
Epitomee |
Weight loss set to be pharmas gain Globes
Read at news.google.com
 |
Epitomee Medical Fundamental Analysis
We analyze Epitomee Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Epitomee Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Epitomee Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Epitomee Medical is rated # 5 in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Epitomee Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Epitomee Medical stock to make a market-neutral strategy. Peer analysis of Epitomee Medical could also be used in its relative valuation, which is a method of valuing Epitomee Medical by comparing valuation metrics with similar companies.
Peers
Epitomee Medical Related Equities
| EMITF | Elbit Imaging | 3.11 | ||||
| HUMX | Human Xtensions | 0.69 | ||||
| BIOV | Bio View | 0.35 | ||||
| ENDY | Endymed | 0.34 | ||||
| INCR | Intercure | 0.32 | ||||
| EPIT | Epitomee Medical | 1.10 | ||||
| SOFW | Sofwave Medical | 2.02 | ||||
| INSL | Insuline Medical | 9.64 |
Complementary Tools for Epitomee Stock analysis
When running Epitomee Medical's price analysis, check to measure Epitomee Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epitomee Medical is operating at the current time. Most of Epitomee Medical's value examination focuses on studying past and present price action to predict the probability of Epitomee Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epitomee Medical's price. Additionally, you may evaluate how the addition of Epitomee Medical to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |